CS logo
small CS logo
Hopital Saint Eloi; Hematologie Oncologie Medicale

Montpellier, France

About Hopital Saint Eloi; Hematologie Oncologie Medicale


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Hopital Saint Eloi; Hematologie Oncologie Medicale


During the past decade, Hopital Saint Eloi; Hematologie Oncologie Medicale conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Saint Eloi; Hematologie Oncologie Medicale" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Hopital Saint Eloi; Hematologie Oncologie Medicale


According to Clinical.Site data, the most researched conditions in "Hopital Saint Eloi; Hematologie Oncologie Medicale" are "Non-Hodgkin's Lymphoma" (2 trials), "B-cell Lymphoma" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Hopital Saint Eloi; Hematologie Oncologie Medicale" in a lesser frequency.

Clinical Trials Intervention Types at Hopital Saint Eloi; Hematologie Oncologie Medicale


Most popular intervention types in "Hopital Saint Eloi; Hematologie Oncologie Medicale" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (3 trials), "Bendamustine" (2 trials), "Doxorubicin" (2 trials), "Obinutuzumab" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Hopital Saint Eloi; Hematologie Oncologie Medicale


The vast majority of trials in "Hopital Saint Eloi; Hematologie Oncologie Medicale" are 4 trials for "All" genders.

Clinical Trials Status at Hopital Saint Eloi; Hematologie Oncologie Medicale


Currently, there are NaN active trials in "Hopital Saint Eloi; Hematologie Oncologie Medicale". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hopital Saint Eloi; Hematologie Oncologie Medicale, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Saint Eloi; Hematologie Oncologie Medicale, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".